[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340625-105":59,"doc-detail-340625-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","calls-to-action-on-lung-cancer-management-and-research","Calls to action on lung cancer management and research","","Lung cancer remains the leading cause of cancer-related deaths globally despite major medical advances. A New York Lung Cancer Foundation consortium convened experts across academia, industry, and patient advocacy to assess current lung cancer diagnosis, treatment, and research, pinpointing gaps and shaping collaborative public health and scientific strategies. The initiative prioritizes eight calls to action, spanning early-stage cure strategies, smoking-independent carcinogenesis research, precision medicine for interception and prevention, equitable implementation, open data sharing, and development of novel immunotherapeutic approaches.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/calls-to-action-on-lung-cancer-management-and-research/340625/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/calls-to-action-on-lung-cancer-management-and-research/340625.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-22","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the purpose of the “Calls to Action” for lung cancer management and research?","Question",{"text":113,"@type":114},"The consortium aimed to assess the current state of lung cancer diagnosis, treatment, and research, identify incomplete understanding, and develop collaborative public health and scientific strategies to improve patient outcomes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How many calls to action are prioritized in the consortium’s plan?",{"text":118,"@type":114},"The consortium prioritized 8 distinct calls to action across prevention, research, collaboration, data access, and treatment development.",{"name":120,"@type":111,"acceptedAnswer":121},"Which prevention and early detection themes are highlighted?",{"text":122,"@type":114},"The document emphasizes that tobacco smoking is the leading risk factor, notes gaps in standardized smoking cessation programs, and discusses additional risks such as vaping/cannabis smoking and environmental factors like air pollution.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},340625,1790118094,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","Calls to action on lung cancer management and research  \nMay-Lucie Meyer1,, Fred R. Hirsch1,*,, PaulA. Bunn2, Peter Ujhazy3, David Fredrickson4, Christine D. Berg5, David P. Carbone6, Balazs Halmos7,, Harpreet Singh8, Hossein Borghaei9,, Andrea Ferris10, Corey Langer11,, Sanja Dacic12, Tony S. Mok13, Solange Peters14,,  \nBruce E. Johnson15  \n1 Hematology and Oncology Department, Tisch Cancer Institute at Mount Sinai, Icahn School of Medicine and Thoracic Oncology Center, New York, NY, United States,  \n2Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, United States,  \n3Translational Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD, United States, 4Astra Zeneca, Washington, DC, United States,  \n5Early Cancer Detection Consultant, Bethesda, MD, United States,  \n6Division of Medical Oncology, The Ohio State University—James Comprehensive Cancer Center, Columbus, OH, United States, 7Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, United States,  \n8US Food and Drug Administration (FDA), Washington, DC, United States, 9Fox Chase Cancer Center, Philadelphia, PA, United States, 10LUNGevity Foundation, Chicago, IL, United States,  \n11Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States, 12Department of Pathology, Yale School of Medicine, New Haven, CT, United States,  \n13State Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, People’s Republic of China, 14Department of Oncology, University Hospital CHUV, Lausanne, Switzerland,  \n15Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States  \n*Corresponding author: Fred R. Hirsch, MD, PhD, Icahn Medical School, Mount Sinai, New York, NY 10029, USA ([fred.hirsch@mssm.edu](fred.hirsch@mssm.edu)) .  \nAbstract  \nLung cancer, the leading cause of cancer-related deaths globally, remains a pressing health issue despite significant medical advances. The New York Lung Cancer Foundation brought together experts from academia, the pharmaceutical and biotech industries as well as organizational leaders and patient advocates, to thoroughly examine the current state of lung cancer diagnosis, treatment, and research. The goal was to identify areas where our understanding is incomplete and to develop collaborative public health and scientific strategies to generate better patient outcomes, as highlighted in our “Calls to Action.” The consortium prioritized 8 different calls to action. These include (1) develop strategies to cure more patients with early-stage lung cancer,(2) investigate carcinogenesis leading to lung cancers in patients without a history of smoking,(3) harness precision medicine for disease interception and prevention,(4) implement solutions to deliver prevention measures and effective therapies to individuals in under-resourced countries,(5) facilitate collaborations with industry to collect and share data and samples,(6) create and maintain open access to big data repositories,(7) develop new immunotherapeutic agents for lung cancer treatment and prevention, and (8) invest in research in both the academic and community settings. These calls to action provide guidance to representatives from academia, the pharmaceutical and biotech industries, organizational and regulatory leaders, and patient advocates to guide ongoing and planned initiatives. Key words: screening; smoking cessation; non–small cell lung cancer; small cell lung cancer; immunotherapy; biomarkers.  \nIntroduction  \nTo address critical issues needed to improve outcomes for patients at risk for and with lung cancer, the New York Lung Cancer Summit gathered global experts from academia, the Food and Drug Administration (FDA), the National Cancer Institute (NCI), pharmaceutical and biotech industries, and patient advocacy groups. The summit a","cbCaiubSOyT1Sf9A","https://ap.wps.com/l/cbCaiubSOyT1Sf9A","pdf",17196897,12,"English","# Abstract\n# Introduction\n# Strategies of prevention and early detection\n## Prevention","[{\"question\":\"What is the purpose of the “Calls to Action” for lung cancer management and research?\",\"answer\":\"The consortium aimed to assess the current state of lung cancer diagnosis, treatment, and research, identify incomplete understanding, and develop collaborative public health and scientific strategies to improve patient outcomes.\"},{\"question\":\"How many calls to action are prioritized in the consortium’s plan?\",\"answer\":\"The consortium prioritized 8 distinct calls to action across prevention, research, collaboration, data access, and treatment development.\"},{\"question\":\"Which prevention and early detection themes are highlighted?\",\"answer\":\"The document emphasizes that tobacco smoking is the leading risk factor, notes gaps in standardized smoking cessation programs, and discusses additional risks such as vaping/cannabis smoking and environmental factors like air pollution.\"}]","Calls to action on lung cancer management and research | PDF",1790037745]